These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20395121)

  • 1. High and low threshold service provision in drug-free settings: Practitioner views.
    Eversman MH
    Int J Drug Policy; 2010 Nov; 21(6):501-6. PubMed ID: 20395121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substance abuse treatment system in the U.S. What is it? What does it do? Myths and misconceptions.
    Rawson RA; Obert JL
    Occup Med; 2002; 17(1):27-39, iii-iv. PubMed ID: 11726334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies.
    Rosenberg H; Phillips KT
    Psychol Addict Behav; 2003 Sep; 17(3):203-10. PubMed ID: 14498814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction programmes in the Asia--Pacific Region.
    Reid G; Devaney ML; Baldwin S
    Drug Alcohol Rev; 2008 Jan; 27(1):95-8. PubMed ID: 18034387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of specialty substance abuse and mental health services in adults with substance use disorders in the community.
    Mojtabai R
    Drug Alcohol Depend; 2005 Jun; 78(3):345-54. PubMed ID: 15893166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mangement of drug problems in Hungary].
    Buda B
    Lege Artis Med; 2009 Sep; 19(8-9):537-41. PubMed ID: 20608432
    [No Abstract]   [Full Text] [Related]  

  • 13. The landscape of services for drug users in Yogyakarta, Indonesia.
    Morrison C; Kurniasih Y; Barton G
    Drug Alcohol Rev; 2012 Jan; 31(1):95-100. PubMed ID: 22141745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse treatment evolves: a follow-up.
    Spath P
    Hosp Peer Rev; 1997 Sep; 22(9):132-4. PubMed ID: 10173140
    [No Abstract]   [Full Text] [Related]  

  • 15. Using the tidal model of mental health recovery to plan primary health care for women in residential substance abuse recovery.
    Young BB
    Issues Ment Health Nurs; 2010 Sep; 31(9):569-75. PubMed ID: 20701419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of an abstinence-oriented, outpatient drug addiction service in Greece.
    Paparrigopoulos T; Liappas J; Mellos E; Rabavilas A
    Psychol Rep; 2007 Jun; 100(3 Pt 1):1024-42. PubMed ID: 17688121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Everyone deserves services no matter what": defining success in harm-reduction-based substance user treatment.
    Lee HS; Zerai A
    Subst Use Misuse; 2010 Dec; 45(14):2411-27. PubMed ID: 20397869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in the impact of comprehensive services in substance abuse treatment.
    Marsh JC; Cao D; D'Aunno T
    J Subst Abuse Treat; 2004 Dec; 27(4):289-300. PubMed ID: 15610830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design of Healthcare for Communities: a study of health care delivery for alcohol, drug abuse, and mental health conditions.
    Sturm R; Gresenz C; Sherbourne C; Minnium K; Klap R; Bhattacharya J; Farley D; Young AS; Burnam MA; Wells KB
    Inquiry; 1999; 36(2):221-33. PubMed ID: 10459376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of drug addicts in the health center].
    Poras JP
    Soins Psychiatr; 1993 Oct; (156):7-12. PubMed ID: 8115875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.